Y is the response Y is % stimulation of RFU and starts at Bottom and goes to Top with a sigmoid shape
Slower escalation may reduce gastrointestinal side effects and moderate rapid weight shifts
Boland BB, Rhodes CJ, Grimsby JS
Verify the medication label and dosing instructions before your first injection: Check that what arrived matches your prescription - verify the form of the active ingredient, dosing schedule, and storage requirements with your dispensing pharmacy
This is the first study to show a clear benefit of GLP-1 receptor agonists on kidney failure or end-stage kidney disease, suggesting they have a key role in kidney-protective and heart-protective treatment for patients with common medical conditions like type 2 diabetes, overweight or obesity with cardiovascular disease, or CKD [chronic kidney disease], said lead author Sunil Badve, professorial fellow at The George Institute for Global Health and UNSW Sydney